Loading...
XJPX
2503
Market cap11bUSD
Apr 08, Last price  
2,030.50JPY
1D
0.89%
1Q
1.93%
Jan 2017
6.78%
Name

Kirin Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
28.25
P/S
0.70
EPS
71.88
Div Yield, %
3.50%
Shrs. gr., 5y
-1.58%
Rev. gr., 5y
3.79%
Revenues
2.34t
+9.56%
1,634,757,326,5701,263,625,000,0001,400,608,000,0001,922,877,000,0002,278,473,000,0002,177,802,000,0002,071,774,000,0002,186,177,000,0002,254,585,000,0002,195,795,000,0002,196,925,000,0002,075,070,000,0001,863,730,000,0001,930,522,000,0001,941,305,000,0001,849,545,000,0001,821,570,000,0001,989,468,000,0002,134,393,000,0002,338,385,000,000
Net income
58.21b
-48.34%
51,377,749,95053,512,000,00066,713,000,00080,182,000,00049,172,000,00011,394,000,0007,407,000,00056,198,000,00085,656,000,00032,392,000,000-47,329,000,000118,158,000,000242,057,000,000164,202,000,00081,438,000,00099,841,000,00059,790,000,000111,007,000,000112,697,000,00058,214,000,000
CFO
242.84b
+19.51%
125,994,052,015123,685,000,000114,585,000,000131,281,000,000189,907,000,000218,025,000,000196,792,000,000212,061,000,000205,517,000,000155,247,000,000171,011,000,000226,468,000,000221,710,000,000198,051,000,000178,826,000,000164,839,000,000219,303,000,000135,562,000,000203,206,000,000242,844,000,000
Dividend
Jun 27, 20250 JPY/sh
Earnings
May 07, 2025

Profile

Kirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
URL
https://www.kirinholdings.co.jp/
IPO date
May 16, 1949
Employees
30,538
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,338,385,000
9.56%
2,134,393,000
7.28%
1,989,468,000
9.22%
Cost of revenue
1,272,430,000
1,933,184,000
2,105,086,000
Unusual Expense (Income)
NOPBT
1,065,955,000
201,209,000
(115,618,000)
NOPBT Margin
45.59%
9.43%
Operating Taxes
53,910,000
46,611,000
47,615,000
Tax Rate
5.06%
23.17%
NOPAT
1,012,045,000
154,598,000
(163,233,000)
Net income
58,214,000
-48.34%
112,697,000
1.52%
111,007,000
85.66%
Dividends
(58,316,000)
(57,500,000)
(53,778,000)
Dividend yield
3.51%
3.44%
3.25%
Proceeds from repurchase of equity
(82,000)
(35,000)
(50,051,000)
BB yield
0.00%
0.00%
3.03%
Debt
Debt current
77,986,000
120,080,000
114,459,000
Long-term debt
779,583,000
670,275,000
471,478,000
Deferred revenue
Other long-term liabilities
296,797,000
119,070,000
234,139,000
Net debt
522,747,000
173,946,000
32,733,000
Cash flow
Cash from operating activities
242,844,000
203,206,000
135,562,000
CAPEX
(180,584,000)
(113,810,000)
(98,479,000)
Cash from investing activities
(329,375,000)
(226,091,000)
(10,399,000)
Cash from financing activities
58,125,000
35,909,000
(167,835,000)
FCF
948,887,000
120,222,000
(290,594,000)
Balance
Cash
118,617,000
140,343,000
96,436,000
Long term investments
216,205,000
476,066,000
456,768,000
Excess cash
217,902,750
509,689,350
453,730,600
Stockholders' equity
1,775,593,000
1,656,362,000
1,479,473,000
Invested Capital
2,470,177,250
1,768,298,650
1,552,121,400
ROIC
47.76%
9.31%
ROCE
39.65%
8.68%
EV
Common stock shares outstanding
809,944
809,853
821,755
Price
2,049.00
-0.82%
2,066.00
2.73%
2,011.00
8.88%
Market cap
1,659,574,883
-0.81%
1,673,156,298
1.25%
1,652,549,305
7.33%
EV
2,534,510,883
2,140,359,298
1,958,463,305
EBITDA
1,161,657,000
288,436,000
(29,681,000)
EV/EBITDA
2.18
7.42
Interest
6,579,000
6,478,000
Interest/NOPBT
3.27%